Holen Sie sich die Stockscreener-App
706.41
1.86%
-13.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$720.21
Offen:
$712.475
24-Stunden-Volumen:
797.05K
Relative Volume:
1.70
Marktkapitalisierung:
$56.48B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.03B
KGV:
56.00
EPS:
12.6148
Netto-Cashflow:
$940.22M
1W Leistung:
+12.45%
1M Leistung:
+12.58%
6M Leistung:
+49.20%
1J Leistung:
+66.92%
1-Tages-Spanne:
$694.00
$720.00
1-Wochen-Bereich:
$628.90
$735.00
52-Wochen-Spanne:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
705.99 | 57.51B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
565.58 | 213.27B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
211.10 | 149.89B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
147.05 | 41.61B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
211.12 | 35.78B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Agree To Buy Idexx Laboratories At $600, Earn 5.3% Annualized Using Options - Nasdaq
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Yahoo Finance
Why retail investors favor IDEXX Laboratories Inc. stockEarnings Performance Report & Free Community Supported Trade Ideas - newser.com
Building trade automation scripts for IDEXX Laboratories Inc.July 2025 Levels & Verified Chart Pattern Signals - newser.com
Is IDEXX Laboratories Inc. stock ready for a breakoutTrade Ideas & Daily Stock Momentum Reports - newser.com
Will earnings trigger a reversal in IDEXX Laboratories Inc.Day Trade & Smart Allocation Stock Reports - newser.com
IDEXX Laboratories Hits New 52-Week High of $734.64, Up 42.24% - Markets Mojo
IDEXX Laboratories Hits Day High with 14.84% Surge in Stock Price - Markets Mojo
Does IDEXX Laboratories Inc. fit your quant trading modelProduct Launch & Verified High Yield Trade Plans - newser.com
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $775.00 - MarketBeat
Will IDEXX Laboratories Inc. stock recover after recent drop2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
Blue Barn Wealth LLC Takes $225,000 Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Jacobson & Schmitt Advisors LLC Grows Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Bridgewater Advisors Inc. Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
415 Shares in IDEXX Laboratories, Inc. $IDXX Acquired by Fullcircle Wealth LLC - MarketBeat
Bank of Montreal Can Boosts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Arkadios Wealth Advisors Acquires New Shares in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX outlines 9.6%–10.3% revenue growth outlook for 2025 amid robust CAG Diagnostics expansion - MSN
Trend analysis for IDEXX Laboratories Inc. this week2025 Risk Factors & Reliable Breakout Forecasts - newser.com
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
UBS Maintains IDEXX Laboratories (IDXX) Neutral Recommendation - Nasdaq
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Idexx Laboratories (IDXX) Just Overtook the 50-Day Moving Average - sharewise.com
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Cullinan Management (CGEM) and Idexx Laboratories (IDXX) - The Globe and Mail
IDEXX Laboratories (IDXX) Sees Target Price Raised by Morgan Sta - GuruFocus
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX) - Yahoo Finance
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $805 - 富途牛牛
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $750 - 富途牛牛
UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating - MarketScreener
IDEXX Laboratories (NASDAQ:IDXX) Hits New 12-Month High Following Earnings Beat - MarketBeat
World Investment Advisors Takes $456,000 Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Releases FY 2025 Earnings Guidance - MarketBeat
Idexx Laboratories stock reaches 52-week high at $693.00 By Investing.com - Investing.com Australia
IDEXX Laboratories (NASDAQ:IDXX) Posts Quarterly Earnings Results, Beats Estimates By $0.26 EPS - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2025 Earnings Call Transcript - Insider Monkey
Bank of New York Mellon Corp Raises Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
A Fresh Look at IDEXX Laboratories (IDXX) Valuation After Raising Full-Year Growth Outlook - Yahoo Finance
Meta Platforms, S&P Global And A Health Care Stock: CNBC's 'Final Trades' - Benzinga
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $775 to $830 - 富途牛牛
Fund Update: 16,825 IDEXX LABS (IDXX) shares added to KEYBANK NATIONAL ASSOCIATION|OH portfolio - Quiver Quantitative
Jefferies Adjusts Price Target on IDEXX Laboratories to $830 From $785, Maintains Buy Rating - MarketScreener
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $805 From $765, Maintains Overweight Rating - MarketScreener
JPMorgan Adjusts Price Target on IDEXX Laboratories to $775 From $675, Maintains Overweight Rating - MarketScreener
BTIG Adjusts Price Target on IDEXX Laboratories to $830 From $785, Maintains Buy Rating - MarketScreener
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $823 From $761, Maintains Outperform Rating - MarketScreener
Rothschild & Co Redburn Adjusts PT on IDEXX Laboratories to $700 From $670, Maintains Neutral Rating - MarketScreener
Why Analysts See the IDEXX Story Shifting With Upgraded Forecasts and Improved Growth Momentum - Yahoo Finance
BTIG Maintains IDEXX Laboratories (IDXX) Buy Recommendation - Nasdaq
IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects (NASDAQ:IDXX) - Seeking Alpha
1,171 Shares in IDEXX Laboratories, Inc. $IDXX Bought by Intellectus Partners LLC - MarketBeat
IDEXX Laboratories (IDXX) Margin Beat Reinforces Premium Valuation Narrative - Yahoo Finance
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):